Mar 15, 2017 - The following slide deck was published by Allergan plc in conjunction with this event.
Mar 13, 2017 - U.S. Patent and Trademark Office (USPTO) Patent Trials and Appeal Board (PTAB) upheld four patents of Acorda's key growth driver, Ampyra.
Mar 13, 2017 - Aerie Pharmaceuticals is a development-stage company focused on the development and commercialization of eye disease therapies, including glaucoma and other eye-diseases.
Mar 10, 2017 - Biotech major, Amgen, Inc.'s (AMGN) shares have risen 12.1% since it reported better-than-expected fourth quarter results on Feb 2.
Mar 09, 2017 - Allergan plc (AGN) announced that its supplemental New Drug Application (sNDA) for its schizophrenia capsules Vraylar has been accepted for review by the FDA.
Mar 08, 2017 - Aerie Pharmaceuticals, Inc. (AERI) posted fourth-quarter 2016 loss of 87 cents per share (including stock-based compensation), wider than both the Zacks Consensus Estimate of a loss of 65 cents
Mar 08, 2017 - President Donald Trump March 7 tweet on increasing competition and lowering drug prices sent fresh shockwaves across the industry.
Feb 27, 2017 - Pharma Industry Outlook - February/March 2017
Feb 13, 2017 - Market futures are very positive this morning, and continue to climb 20 minutes before the opening bell sounds.
Aug 08, 2016 - Allergan Plc (NYSE:AGN)Q2 2016 Earnings CallAugust 08, 2016 8:30 am ETExecutivesLisa M. DeFrancesco - Vice President-Investor RelationsBrenton L. Saunders - President, Chief Executive Officer & Direct